AneCDotes Newsletter
Click on the image below to download the latest issue of AneCDotes, the newsletter for patients in the Laquinimod for Crohn's Disease trial.
Welcome to the Crohn's study clinical trial website
This study is designed to explore how effective, how safe and how tolerable different doses of a new drug, called laquinimod, is in patients who have Crohn's Disease. Laquinimod is a new investigational drug that is taken by mouth once daily. It is hoped that laquinimod will be safe, tolerable and effective in reducing the score of a standard scale that is used to assess Crohn's disease activity.
This website aims to give you more information in order for you to make an informed decision about whether or not to participate in this clinical trial. It includes general information about clinical trials and clinical trial participation, kindly provided by the UK Clinical Research Collaboration. It includes information on the rights and responsibilities of study volunteers and a list of important questions for someone to consider before joining this study.
